PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN Drug Patent Profile

✉ Email this page to a colleague

Propoxyphene Napsylate And Acetaminophen is a drug marketed by Able, Actavis Elizabeth, Cornerstone, Halsey, Ivax Sub Teva Pharms, Mallinckrodt, Mirror Pharms, Mutual Pharm, Mylan, Mylan Pharms Inc, Sandoz, Superpharm, Teva, Vintage Pharms, Watson Labs, Watson Labs Florida, and Wockhardt Ltd. and is included in twenty-six NDAs.

The generic ingredient in PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN is acetaminophen; propoxyphene napsylate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; propoxyphene napsylate profile page.

US Patents:	0
Applicants:	17
NDAs:	26
Raw Ingredient (Bulk) Api Vendors:	1
Patent Applications:	8
Formulation / Manufacturing:	see details
DailyMed Link:	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN at DailyMed

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wockhardt Ltd	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN	acetaminophen; propoxyphene napsylate	TABLET;ORAL	077677-002	Mar 16, 2007		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Able	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN	acetaminophen; propoxyphene napsylate	TABLET;ORAL	075838-001	Jul 11, 2001		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Superpharm	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN	acetaminophen; propoxyphene napsylate	TABLET;ORAL	071319-001	Jan 6, 1987		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Watson Labs	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN	acetaminophen; propoxyphene napsylate	TABLET;ORAL	070399-001	Dec 18, 1986		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration